MARAVIROC
Generic: MARAVIROC
Camber PharmaceuticalsManufacturer
ORALRoute
MARAVIROCActive Substance
2022-02-07Original Approval
MARAVIROC is FDA application ANDA203347, sponsored by HETERO LABS LTD III. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
VIROLOGIC FAILURE
138 reports
2
VIRAL MUTATION IDENTIFIED
128 reports
3
PATHOGEN RESISTANCE
124 reports
4
DRUG INTERACTION
79 reports
5
DRUG RESISTANCE
78 reports
6
DRUG INEFFECTIVE
77 reports
7
OFF LABEL USE
63 reports
8
TREATMENT FAILURE
63 reports
9
TREATMENT NONCOMPLIANCE
57 reports
10
NAUSEA
50 reports